Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells

This study revealed an upregulation of FAO in paclitaxel-tolerant ovarian cancer persister cells and provided a prospective paclitaxel-ST1326 combination therapy targeting persister cells that may prevent the development of acquired drug resistance and achieve superior long-term ovarian cancer control in the future. Our research established a conceptual framework for advancing personalized treatment approaches and enhancing patient outcomes in ovarian cancer therapy.

Authors

Institutions

Publication Details

Journal
Journal of Advanced Research
Published
2025-03-17
DOI
https://doi.org/10.1016/j.jare.2025.03.026
Citations
4
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
3.75

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells

Hanwen Chen, Hui‐Yi Lin, Dajing Xia, Yihua Wu et al.
4 citations
Journal of Advanced Research
Cancer, Lipids, and Metabolism
3.75
article

Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells

Hanwen Chen, Hui‐Yi Lin, Dajing Xia, Yihua Wu, Yite Xue, Conghui Wang, Xiaodong Cheng, Lingfang Wang, Zhi‐Ming Zheng, Yuqing Shen, Xiao Li, Yanan Zhang, Hui Wang, Junfen Xu, Weiguo Lü, Fenfen Wang
article en
4 citations

Abstract

This study revealed an upregulation of FAO in paclitaxel-tolerant ovarian cancer persister cells and provided a prospective paclitaxel-ST1326 combination therapy targeting persister cells that may prevent the development of acquired drug resistance and achieve superior long-term ovarian cancer control in the future. Our research established a conceptual framework for advancing personalized treatment approaches and enhancing patient outcomes in ovarian cancer therapy.

Journal of Advanced ResearchVol. 79
Peking University (CN), Peking University People's Hospital (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 7%
Cancer, Lipids, and Metabolism
3.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.